coronary stent 2

License Raj Makes A Comeback

National Pharmaceutical Pricing Authority’s move to cap pricing of coronary stents would adversely affect well-to-do patients and medical tourism industry in India After the Delhi High court passed the order …

License Raj Makes A Comeback Read More »